Brief: 9 Meters Biopharma Inc Doses First Patients In Phase 1B/2A Clinical Trial In Short Bowel Syndrome
July 21 (Reuters) - 9 Meters Biopharma Inc NMTR.O :
* 9 METERS BIOPHARMA INC - DOSES FIRST PATIENTS IN PHASE
1B/2A
CLINICAL TRIAL IN SHORT BOWEL SYNDROME
Source: [ID:https://bit.ly/2E6gDYH]
Further company coverage: NMTR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 9 Meters Biopharma
See all newsIllumina cuts annual profit forecast as biotech funding woes linger (updated)
Illumina cuts annual profit forecast
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
9 Meters Biopharma falls after filing for bankruptcy protection